439 related articles for article (PubMed ID: 33385130)
1.
Tu T; Zehnder B; Qu B; Urban S
JHEP Rep; 2021 Feb; 3(1):100195. PubMed ID: 33385130
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B virus genome recycling and de novo secondary infection events maintain stable cccDNA levels.
Ko C; Chakraborty A; Chou WM; Hasreiter J; Wettengel JM; Stadler D; Bester R; Asen T; Zhang K; Wisskirchen K; McKeating JA; Ryu WS; Protzer U
J Hepatol; 2018 Dec; 69(6):1231-1241. PubMed ID: 30142426
[TBL] [Abstract][Full Text] [Related]
3. Cellular DNA Topoisomerases Are Required for the Synthesis of Hepatitis B Virus Covalently Closed Circular DNA.
Sheraz M; Cheng J; Tang L; Chang J; Guo JT
J Virol; 2019 Jun; 93(11):. PubMed ID: 30867306
[TBL] [Abstract][Full Text] [Related]
4. Unusual Features of Sodium Taurocholate Cotransporting Polypeptide as a Hepatitis B Virus Receptor.
Li J; Zong L; Sureau C; Barker L; Wands JR; Tong S
J Virol; 2016 Sep; 90(18):8302-13. PubMed ID: 27384660
[TBL] [Abstract][Full Text] [Related]
5. Pregenomic RNA Launch Hepatitis B Virus Replication System Facilitates the Mechanistic Study of Antiviral Agents and Drug-Resistant Variants on Covalently Closed Circular DNA Synthesis.
Zhao Q; Chang J; Rijnbrand R; Lam AM; Sofia MJ; Cuconati A; Guo JT
J Virol; 2022 Dec; 96(24):e0115022. PubMed ID: 36448800
[TBL] [Abstract][Full Text] [Related]
6. DNA Polymerase κ Is a Key Cellular Factor for the Formation of Covalently Closed Circular DNA of Hepatitis B Virus.
Qi Y; Gao Z; Xu G; Peng B; Liu C; Yan H; Yao Q; Sun G; Liu Y; Tang D; Song Z; He W; Sun Y; Guo JT; Li W
PLoS Pathog; 2016 Oct; 12(10):e1005893. PubMed ID: 27783675
[TBL] [Abstract][Full Text] [Related]
7. Proteomic Analysis of Nuclear Hepatitis B Virus Relaxed Circular DNA-Associated Proteins Identifies UV-Damaged DNA Binding Protein as a Host Factor Involved in Covalently Closed Circular DNA Formation.
Marchetti AL; Zhang H; Kim ES; Yu X; Jang S; Wang M; Guo H
J Virol; 2022 Jan; 96(2):e0136021. PubMed ID: 34705558
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B Virus Capsid: The Core in Productive Entry and Covalently Closed Circular DNA Formation.
Mendenhall MA; Hong X; Hu J
Viruses; 2023 Feb; 15(3):. PubMed ID: 36992351
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B Virus DNA Integration Occurs Early in the Viral Life Cycle in an
Tu T; Budzinska MA; Vondran FWR; Shackel NA; Urban S
J Virol; 2018 Jun; 92(11):. PubMed ID: 29437961
[TBL] [Abstract][Full Text] [Related]
10. Mitosis of hepatitis B virus-infected cells
Tu T; Zehnder B; Wettengel JM; Zhang H; Coulter S; Ho V; Douglas MW; Protzer U; George J; Urban S
JHEP Rep; 2022 Sep; 4(9):100514. PubMed ID: 35898957
[TBL] [Abstract][Full Text] [Related]
11. A new high-content screening assay of the entire hepatitis B virus life cycle identifies novel antivirals.
Yang J; König A; Park S; Jo E; Sung PS; Yoon SK; Zusinaite E; Kainov D; Shum D; Windisch MP
JHEP Rep; 2021 Aug; 3(4):100296. PubMed ID: 34222850
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis B Virus Core Protein Is Not Required for Covalently Closed Circular DNA Transcriptional Regulation.
Zhong Y; Wu C; Xu Z; Teng Y; Zhao L; Zhao K; Wang J; Wang W; Zhan Q; Zhu C; Chen X; Liang K; Cheng X; Xia Y
J Virol; 2022 Nov; 96(21):e0136222. PubMed ID: 36226986
[TBL] [Abstract][Full Text] [Related]
13. Serum hepatitis B core-related antigen (HBcrAg) correlates with covalently closed circular DNA transcriptional activity in chronic hepatitis B patients.
Testoni B; Lebossé F; Scholtes C; Berby F; Miaglia C; Subic M; Loglio A; Facchetti F; Lampertico P; Levrero M; Zoulim F
J Hepatol; 2019 Apr; 70(4):615-625. PubMed ID: 30529504
[TBL] [Abstract][Full Text] [Related]
14. A novel method to precisely quantify hepatitis B virus covalently closed circular (ccc)DNA formation and maintenance.
Tu T; Zehnder B; Qu B; Ni Y; Main N; Allweiss L; Dandri M; Shackel N; George J; Urban S
Antiviral Res; 2020 Sep; 181():104865. PubMed ID: 32726641
[TBL] [Abstract][Full Text] [Related]
15. T5 Exonuclease Hydrolysis of Hepatitis B Virus Replicative Intermediates Allows Reliable Quantification and Fast Drug Efficacy Testing of Covalently Closed Circular DNA by PCR.
Qu B; Ni Y; Lempp FA; Vondran FWR; Urban S
J Virol; 2018 Dec; 92(23):. PubMed ID: 30232183
[TBL] [Abstract][Full Text] [Related]
16. Rebound of HBV DNA after cessation of nucleos/tide analogues in chronic hepatitis B patients with undetectable covalently closed.
Lai CL; Wong DK; Wong GT; Seto WK; Fung J; Yuen MF
JHEP Rep; 2020 Jun; 2(3):100112. PubMed ID: 32462119
[TBL] [Abstract][Full Text] [Related]
17. Reduction of covalently closed circular DNA with long-term nucleos(t)ide analogue treatment in chronic hepatitis B.
Lai CL; Wong D; Ip P; Kopaniszen M; Seto WK; Fung J; Huang FY; Lee B; Cullaro G; Chong CK; Wu R; Cheng C; Yuen J; Ngai V; Yuen MF
J Hepatol; 2017 Feb; 66(2):275-281. PubMed ID: 27639844
[TBL] [Abstract][Full Text] [Related]
18. Evidence for long-term association of virion-delivered HBV core protein with cccDNA independently of viral protein production.
Lucifora J; Pastor F; Charles É; Pons C; Auclair H; Fusil F; Rivoire M; Cosset FL; Durantel D; Salvetti A
JHEP Rep; 2021 Oct; 3(5):100330. PubMed ID: 34409278
[TBL] [Abstract][Full Text] [Related]
19. Limited disassembly of cytoplasmic hepatitis B virus nucleocapsids restricts viral infection in murine hepatic cells.
Zhao K; Guo F; Wang J; Zhong Y; Yi J; Teng Y; Xu Z; Zhao L; Li A; Wang Z; Chen X; Cheng X; Xia Y
Hepatology; 2023 Apr; 77(4):1366-1381. PubMed ID: 35718932
[TBL] [Abstract][Full Text] [Related]
20. Evaluation and identification of hepatitis B virus entry inhibitors using HepG2 cells overexpressing a membrane transporter NTCP.
Iwamoto M; Watashi K; Tsukuda S; Aly HH; Fukasawa M; Fujimoto A; Suzuki R; Aizaki H; Ito T; Koiwai O; Kusuhara H; Wakita T
Biochem Biophys Res Commun; 2014 Jan; 443(3):808-13. PubMed ID: 24342612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]